Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
University Hospital, Cincinnati, Ohio, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
University of Utah, Salt Lake City, Utah, United States
Nationwide Children's Hospital, Columbus, Ohio, United States
UHN Toronto Western Hospital, Toronto, Ontario, Canada
Massachusetts General Hospital, Boston, Massachusetts, United States
Gastroenterology Unit, King Chulalongkorn Memorial Hospital, Patumwan, Bangkok, Thailand
Oslo University Hospital, Oslo, Norway
Chhatrapati Shahuji Maharaj Medical University, U.P. & G.M. & Associated Hospitals, Lucknow, Uttar Pradesh, India
University Children's Hospital Zurich, Zurich, Switzerland
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.